These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13976538)

  • 21. [Pharmacologic studies on a new 19-nor protein anabolic steroid. 2. A study of the influence of 4-hydroxy-19-nortestosterone-17-cyclopentyl propionate on metabolism, especially on the protein anabolic mechanism].
    Kikuta K
    Zasshi Tokyo Ika Daigaku; 1967 Sep; 25(5):565-81. PubMed ID: 5625986
    [No Abstract]   [Full Text] [Related]  

  • 22. THE FINDINGS ON THE USE OF 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE IN CHRONIC PULMONARY TUBERCULOSIS.
    FOSSATI C
    Panminerva Med; 1963 Sep; 5():274-9. PubMed ID: 14049151
    [No Abstract]   [Full Text] [Related]  

  • 23. THE EFFECT OF 17-ALPHA-ETHYL-19-NORTESTOSTERONE AND 17-ALPHA-ETHYL-19-NORTESTERONE 3-ENOL-PROPIONATE ON GROWTH AND ENDOCRINE FUNCTION IN NORMAL YOUNG MALES OF SHORT STATURE.
    GELLER J
    Acta Endocrinol (Copenh); 1964 Jan; 45():13-25. PubMed ID: 14102665
    [No Abstract]   [Full Text] [Related]  

  • 24. [On results obtained by the use of 4-hydroxy-19-nortestosterone-17-cyclopentylpropionate in patients with chronic pulmonary tuberculosis].
    FOSSATI C
    Gazz Med Ital; 1963 Mar; 122():93-8. PubMed ID: 13958879
    [No Abstract]   [Full Text] [Related]  

  • 25. Experiences in the pediatric use of 19-nortestosterone furylpropionate for premature babies.
    Irie H; Segawa R
    Yokohama Med Bull; 1965 Aug; 16(4):165-72. PubMed ID: 5880943
    [No Abstract]   [Full Text] [Related]  

  • 26. [RESEARCH ON FATIGUE PREVENTION. (ACTION OF 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE)].
    MAGLIO A; POTENZA P; FRANCESCONI A
    Ann Med Nav (Roma); 1963; 68():797-802. PubMed ID: 14089321
    [No Abstract]   [Full Text] [Related]  

  • 27. [BACTERICIDAL POWER OF THE BLOOD IN PATIENTS CONVALESCING FROM TYPHOID FEVER SUBJECTED TO ANTITYPHOID VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE].
    LOSCHIAVO F
    G Mal Infett Parassit; 1965 Feb; 17():59-62. PubMed ID: 14327118
    [No Abstract]   [Full Text] [Related]  

  • 28. [COMPLEMENT ACTIVITY IN ATHLETES SUBJECTED TO ANTITETANUS VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE. II].
    LOSCHIAVO F; GALLO D; BUCCHIARONE A
    Med Sport (Roma); 1965 May; 83():332-6. PubMed ID: 14344534
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies related to the origin of C18 neutral steroids isolated from extracts of urine from the male horse: the identification of urinary 19-oic acids and their decarboxylation to produce estr-4-en-17beta-ol-3-one (19-nortestosterone) and estr-4-ene-3,17-dione (19-norandrost-4-ene-3,17-dione) during sample processing.
    Houghton E; Teale P; Dumasia MC
    Anal Chim Acta; 2007 Mar; 586(1-2):196-207. PubMed ID: 17386712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activity of 4-hydroxy-17alpha-methyl-19-nortestosterone on some experimental tumors].
    DI MARCO A; GAETANI M; DORIGOTTI L; BELLINI O
    Tumori; 1962; 48():361-72. PubMed ID: 14027562
    [No Abstract]   [Full Text] [Related]  

  • 31. [GLUTAMIC-OXALACETIC TRANSAMINASE AND GLUTAMIC-PYRUVIC TRANSAMINASE IN ATHLETES SUBJECTED TO ANTITETANUS VACCINATION AND TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE. I].
    LOSCHIAVO F; BUCCHIARONE A; GALLO D
    Med Sport (Roma); 1965 May; 83():327-31. PubMed ID: 14344533
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of 4-hydroxy-19-nortestosterone-17-cyclopentylpropionate on periodontal, dental and oral tissues. (Histological study on albino rats)].
    Rossi A; Calò E
    Riv Ital Stomatol; 1966 Dec; 21(12):1255-66. PubMed ID: 5227855
    [No Abstract]   [Full Text] [Related]  

  • 33. Growth observations during the administration of a new steroid; an exploratory clinical study with 17-ethyl-19-nortestosterone.
    BAYER LM
    Stanford Med Bull; 1957 Nov; 15(4):308-15. PubMed ID: 13495744
    [No Abstract]   [Full Text] [Related]  

  • 34. ANABOLIC STEROIDS: THEIR CLINICAL USE AND SPECIFIC DANGERS IN PEDIATRICS.
    LARON Z; GITTER S
    Clin Pediatr (Phila); 1963 Nov; 2():594-600. PubMed ID: 14085300
    [No Abstract]   [Full Text] [Related]  

  • 35. [GLUTAMIC-OXALACETIC TRANSAMINASE AND GLUTAMIC-PYRUVIC TRANSAMINASE IN TYPHOID PATIENTS TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYLPROPIONATE IN THE COURSE OF CHLORAMPHENICOL-PREDNISONE THERAPY].
    LOSCHIAVO F; GALLO D
    Riforma Med; 1964 Nov; 78():1308-9. PubMed ID: 14229217
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of the anabolic steroid nortestosterone phenylpropionate on the hematotoxic action of cyclophosphamide].
    Fölsch E; Brügger W; Immich H
    Verh Dtsch Ges Inn Med; 1967; 73():453-7. PubMed ID: 5591798
    [No Abstract]   [Full Text] [Related]  

  • 37. Favourable effect of durabolin (19-nor-androstenolon-phenyl-propionate) on diabetic retinopathy.
    BEAUMONT P; vd BOOGAARD J
    Ophthalmologica; 1960 Jun; 139():480-4. PubMed ID: 13797980
    [No Abstract]   [Full Text] [Related]  

  • 38. [The treatment of growth disorders with anabolic steroids and growth hormone].
    PRADER A; ILLING R
    Dtsch Med J; 1962 Sep; 13():547-9. PubMed ID: 13985886
    [No Abstract]   [Full Text] [Related]  

  • 39. [USE OF ANABOLIC STEROIDS IN PEDIATRICS, THEIR SIDE-EFFECTS AND COUNTER-MEASURES].
    HOTTA T; TAKITA K; ANDO G; KACHIBE T
    Chiryo; 1964; 46():737-44. PubMed ID: 14149976
    [No Abstract]   [Full Text] [Related]  

  • 40. A long-acting anabolic steroid: 4-hydroxy-19-nortestosterone-17-cyclopentylpropionate.
    SALA G; BALDRATTI G
    Endocrinology; 1963 Mar; 72():494-5. PubMed ID: 13990996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.